Ocugen Inc (OCGN)
$1.64
0.02 (1.20%)
OCGN Stock Quote Delayed 30 Minutes
Sell Ocugen Stock Before the Other Shoe Finally Drops
The bad news with Covaxin hasn't sunk in yet with OCGN stock investors, so get out while the stock still remains elevated.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
422.02M
PE Ratio
-6.83
EPS
-0.24
Volume (Avg. Vol.)
3.11M
Day's Range
$1.60 - $1.69
52-Week Range
$0.35 - $2.11
Dividend & Yield
N/A (N/A)
OCGN Stock Predictions, Articles, and Ocugen Inc News
Get Rid of Ocugen Stock While You Can as the Bad News Piles Up
After OCGN stock rallied due to factors that were not based on fundamentals, investors should sell the shares.
It’s Time to Admit Defeat and Dump Ocugen Stock as a Covid Play
After the FDA rejected Covaxin, Ocugen has almost no chance of generating profits from the shot. OCGN stock is a great short.
OCGN Stock: Ocugen Fans Should Be Cheering This COVAXIN News
OCGN stock saw a glimmer of hope today. Where the company took a hit last week in deserting EUA, it is gaining today with a new partnership.
Meme Stocks: The Top 10 Reddit Stocks Seeing the Most Chatter Thursday
Meme stocks continue to be a hot topic among Reddit traders and that means there's plenty of discussion taking place over on WallStreetBets.
OCGN Stock: The COVAXIN News That Has Ocugen Plunging Today
Retail investors refuse to let OCGN stock die, even as the company makes it known that it wouldn't be applying for a crucial authorization.
What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.
So what did the stock market do today? Investors scrutinized updates to the Colonial Pipeline saga and bet on meme stocks.
OCGN stock: The Big COVAXIN News Boosting Ocugen Today
Today, OCGN stock is on the move as the company announced its intention to expand its commercialization rights to include Canada.
When It Comes to Ocugen Stock, I’m Damned If I Do or Don’t
After sprinting to $16.20 in early May, Ocugen’s fallen back to earth. What does it have to do to get OCGN stock back into double digits?
The Same Problems Persist for Ocugen in Marketing Covaxin
OCGN stock is attempting an upward move on unrealistic expectations. There is no reason to believe it can move upward long term.
FDA’s Vaccine Attitude, New Data Don’t Bode Well for Ocugen Stock
The FDA's recent warning that it could reject some applications for EUAs from vaccine makers does not portend well for Ocugen's aspirations. OCGN stock remains an excellent name to sell short.
Ocugen Stock Is a Speculative Covid-19 Vaccine Bet
OCGN stock is a speculative bet. FDA approval of Covaxin would boost the shares. However, the firm's revenue potential is limited.
Ocugen Stock Will Probably Drop Below $1
Ocugen will only make money from sales of its vaccine in the United States, but by the time that's possible, it'll be too late.
Take Your Ocugen Stock Profits and Run If You Haven’t Already
While OCGN stock produced one of the most remarkable rides in the market, it’s time to get off this train before it derails.
OCGN Stock: The Big FDA News Lifting Ocugen Shares Today
Ocugen has swung to new highs and lows this year on news around its partnership for Covaxin. Today's announcement could stoke further progress speculation.
Take Profits If You Own Ocugen Stock, but Now’s Not the Time to Buy
As Ocugen has a long way to go to get approval from the FDA and commercialize Covaxine, OCGN stock will not likely to reach new highs soon.
Ocugen Faces Long Odds Before Gaining From Its Covid-19 Support Role
Ocugen has skin in the Covid-19 vaccine game. But the company faces long odds on its partnership providing a long-term boost for OCGN stock.
Stay On The Sidelines With Ocugen Stock
The small biopharmaceutical company has a promising Covid-19 vaccine, but the timing of its approval remains a question mark for OCGN stock.
Ocugen Stock Is Left Behind As the U.S. Emerges From the Pandemic
There seems to be no need for Covaxin in the U.S. and there are no indications that the U.S. is considering approving it. Consequently, OCGN stock is worth shorting.
